Systemic regulation of angiogenesis and matrix degradation in bone regeneration - Distraction osteogenesis compared to rigid fracture healing

Bone

Volumn 37, Issue 6, 2005, Pages 781-790

  Weiss, S ^a   Zimmermann, G ^b   Baumgart, R ^c   Kasten, P ^a   Bidlingmaier, M ^c   Henle, P ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b BG UNFALLKLINIK LUDWIGSHAFEN   (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

Author keywords

Angiogenesis; Distraction osteogenesis; Matrix degradation; Matrix metalloproteinases; Systemic regulation

Indexed keywords

ANGIOGENIC FACTOR; ANGIOGENIN; COLLAGENASE 3; GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; VASCULOTROPIN;

ADULT; ANGIOGENESIS; ARTICLE; BLOOD SAMPLING; BONE REGENERATION; CALLUS; COMMERCIAL PHENOMENA; CONTROLLED STUDY; DISTRACTION OSTEOGENESIS; ELECTIVE SURGERY; ENZYME BLOOD LEVEL; ENZYME DEGRADATION; ENZYME IMMUNOASSAY; ENZYME REGULATION; EXTRACELLULAR MATRIX; FEMALE; HUMAN; INTERMETHOD COMPARISON; LEG LENGTHENING; MALE; OSTEOTOMY; POSTOPERATIVE PERIOD; PROTEIN ANALYSIS; QUANTITATIVE ANALYSIS; RIGIDITY; STANDARD; STANDARDIZATION;

ADULT; AGED; ANGIOGENIC PROTEINS; BIOLOGICAL MARKERS; BONES OF LOWER EXTREMITY; BONY CALLUS; COLLAGENASES; FEMALE; FRACTURE HEALING; HUMANS; MALE; MATRIX METALLOPROTEINASE 13; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASES; MIDDLE AGED; NEOVASCULARIZATION, PHYSIOLOGIC; OSTEOGENESIS, DISTRACTION; OSTEOTOMY; RIBONUCLEASE, PANCREATIC; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TISSUE INHIBITOR OF METALLOPROTEINASES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 28844477589     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2005.06.014     Document Type: Article

References (44)

1. J. Lammens, Z. Liu, J. Aerssens, J. Dequeker, and G. Fabry Distraction bone healing versus osteotomy healing: a comparative biochemical analysis J. Bone Miner. Res. 13 2 1998 279 286
2. S. Weiss, R. Baumgart, M. Jochum, C.J. Strasburger, and M. Bidlingmaier Systemic regulation of distraction osteogenesis: a cascade of biochemical factors J. Bone Miner. Res. 17 7 2002 1280 1289
3. O. Holbein, C. Neidlinger-Wilke, G. Suger, L. Kinzl, and L. Claes Ilizarov callus distraction produces systemic bone cell mitogens J. Orthop. Res. 13 4 1995 629 638
4. D. Kaspar, C. Neidlinger-Wilke, O. Holbein, L. Claes, and A. Ignatius Mitogens are increased in the systemic circulation during bone callus healing J. Orthop. Res. 21 2 2003 320 325
5. C. Eingartner, S. Coerper, J. Fritz, C. Gaissmaier, G. Koveker, and K. Weise Growth factors in distraction osteogenesis. Immuno-histological pattern of TGF-beta1 and IGF-I in human callus induced by distraction osteogenesis Int. Orthop. 23 5 1999 253 259
6. J. Glowacki Angiogenesis in fracture repair Clin. Orthop. 355 Suppl. 1998 S82 S89
7. D.J. Strydom The angiogenins Cell. Mol. Life Sci. 54 8 1998 811 824
8. C. Fisher, S. Gilbertson-Beadling, E.A. Powers, G. Petzold, R. Poorman, and M.A. Mitchell Interstitial collagenase is required for angiogenesis in vitro Dev. Biol. 162 2 1994 499 510
9. Q.X. Sang Complex role of matrix metalloproteinases in angiogenesis Cell. Res. 8 3 1998 171 177
10. T.H. Vu, J.M. Shipley, and G. Bergers MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes Cell 93 3 1998 411 422
11. C. Colnot, Z. Thompson, T. Miclau, Z. Werb, and J.A. Helms Altered fracture repair in the absence of MMP9 Development 130 17 2003 4123 4133
12. C. Filanti, G.R. Dickson, and D. Di Martino The expression of metalloproteinase-2, -9, and -14 and of tissue inhibitors-1 and -2 is developmentally modulated during osteogenesis in vitro, the mature osteoblastic phenotype expressing metalloproteinase-14 J. Bone Miner. Res. 15 11 2000 2154 2168
13. I. Stamenkovic Extracellular matrix remodelling: the role of matrix metalloproteinases J. Pathol. 200 4 2003 448 464
14. T.H. Vu, and Z. Werb Matrix metalloproteinases: effectors of development and normal physiology Genes Dev. 14 17 2000 2123 2133
15. R.S. Carvalho, T.A. Einhorn, and W. Lehmann The role of angiogenesis in a murine tibial model of distraction osteogenesis Bone 34 5 2004 849 861
16. D.M. Pacicca, N. Patel, and C. Lee Expression of angiogenic factors during distraction osteogenesis Bone 33 6 2003 889 898
17. L.C. Gerstenfeld, D.M. Cullinane, G.L. Barnes, D.T. Graves, and T.A. Einhorn Fracture healing as a post-natal developmental process: molecular, spatial, and temporal aspects of its regulation J. Cell. Biochem. 88 5 2003 873 884
18. J. Aronson Experimental assessment of bone regenerate quality during distraction osteogenesis C. Brighton G. Friedländer J.M. Lane Bone formation and repair 1994 American Academy of Orthopaedic Surgeons Rosemont, USA 441 463
19. D.L. Hulboy, L.A. Rudolph, and L.M. Matrisian Matrix metalloproteinases as mediators of reproductive function Mol. Hum. Reprod. 3 1 1997 27 45
20. G.A. Ilizarov The tension-stress effect on the genesis and growth of tissues: Part I. The influence of stability of fixation and soft-tissue preservation Clin. Orthop. 238 1989 249 281
21. G. Li, A.H. Simpson, J. Kenwright, and J.T. Triffitt Effect of lengthening rate on angiogenesis during distraction osteogenesis J. Orthop. Res. 17 3 1999 362 367
22. M. Vauhkonen, J. Peltonen, E. Karaharju, K. Aalto, and I. Alitalo Collagen synthesis and mineralization in the early phase of distraction bone healing Bone Miner. 10 3 1990 171 181
23. R. Baumgart, A. Betz, and L. Schweiberer A fully implantable motorized intramedullary nail for limb lengthening and bone transport Clin. Orthop. 343 1997 135 143
24. D.D. Marucci, Y. Yu, J. McTavish, B.S. Fiona, M.D. Poole, and W.R. Walsh Matrix metalloproteinases and their inhibitors in bone remodelling following distraction osteogenesis of the sheep mandible J. Craniomaxillofac. Surg. 30 4 2002 208 212
25. W. Lehmann, C.M. Edgar, and K. Wang Tumor necrosis factor alpha (TNF-alpha) coordinately regulates the expression of specific matrix metalloproteinases (MMPS) and angiogenic factors during fracture healing Bone 36 2 2005 300 310
26. S.D. Shapiro Matrix metalloproteinase degradation of extracellular matrix: biological consequences Curr. Opin. Cell Biol. 10 5 1998 602 608
27. H.P. Gerber, T.H. Vu, A.M. Ryan, J. Kowalski, Z. Werb, and N. Ferrara VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation Nat. Med. 5 6 1999 623 628
28. A.H. Baker, D.R. Edwards, and G. Murphy Metalloproteinase inhibitors: biological actions and therapeutic opportunities J. Cell Sci. 115 Pt. 19 2002 3719 3727
29. J.F. Woessner Jr. Matrix metalloproteinase inhibition. From the Jurassic to the third millennium Ann. N. Y. Acad. Sci. 878 1999 388 403
30. L. Rifas, A. Fausto, M.J. Scott, L.V. Avioli, and H.G. Welgus Expression of metalloproteinases and tissue inhibitors of metalloproteinases in human osteoblast-like cells: differentiation is associated with repression of metalloproteinase biosynthesis Endocrinology 134 1 1994 213 221
31. T. Sobue, Y. Hakeda, and Y. Kobayashi Tissue inhibitor of metalloproteinases 1 and 2 directly stimulate the bone-resorbing activity of isolated mature osteoclasts J. Bone Miner. Res. 16 12 2001 2205 2214
32. R. Visse, and H. Nagase Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry Circ. Res. 92 8 2003 827 839
33. S. Varghese, M.L. Ramsby, J.J. Jeffrey, and E. Canalis Basic fibroblast growth factor stimulates expression of interstitial collagenase and inhibitors of metalloproteinases in rat bone cells Endocrinology 136 5 1995 2156 2162
34. S. Varghese, and E. Canalis Regulation of collagenase-3 by bone morphogenetic protein-2 in bone cell cultures Endocrinology 138 3 1997 1035 1040
35. H.Y. Yeung, S.K. Lee, K.P. Fung, and K.S. Leung Expression of basic fibroblast growth factor during distraction osteogenesis Clin. Orthop. 385 2001 219 229
36. A.N. Murphy, E.J. Unsworth, and W.G. Stetler-Stevenson Tissue inhibitor of metalloproteinases-2 inhibits bFGF-induced human microvascular endothelial cell proliferation J. Cell. Physiol. 157 2 1993 351 358
37. V.M. Kahari, and U. Saarialho-Kere Matrix metalloproteinases and their inhibitors in tumour growth and invasion Ann. Med. 31 1 1999 34 45
38. H. Birkedal-Hansen Role of matrix metalloproteinases in human periodontal diseases J. Periodontol. 64 5 Suppl. 1993 474 484
39. N. Hansen-Algenstaedt, P. Algenstaedt, and A. Bottcher Bilaterally increased VEGF-levels in muscles during experimental unilateral callus distraction J. Orthop. Res. 21 5 2003 805 812
40. J.T. Street, J.H. Wang, Q.D. Wu, A. Wakai, A. McGuinness, and H.P. Redmond The angiogenic response to skeletal injury is preserved in the elderly J. Orthop. Res. 19 6 2001 1057 1066
41. S. Jimi, K. Ito, and K. Kohno Modulation by bovine angiogenin of tubular morphogenesis and expression of plasminogen activator in bovine endothelial cells Biochem. Biophys. Res. Commun. 211 2 1995 476 483
42. H. Burgmann, U. Hollenstein, and T. Maca Increased serum laminin and angiogenin concentrations in patients with peripheral arterial occlusive disease J. Clin. Pathol. 49 6 1996 508 510
43. T.A. Einhorn, R.J. Majeska, E.B. Rush, P.M. Levine, and M.C. Horowitz The expression of cytokine activity by fracture callus J. Bone Miner. Res. 10 8 1995 1272 1281
44. H. Yoshiji, S.R. Harris, and E. Raso Mammary carcinoma cells over-expressing tissue inhibitor of metalloproteinases-1 show enhanced vascular endothelial growth factor expression Int. J. Cancer 75 1 1998 81 87